Package Leaflet: Information for the User
Desogestrel STADA 75 micrograms tablets EFG
Read this package leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the package leaflet:
Desogestrel STADA is used to prevent pregnancy. Desogestrel contains a small amount of a type of female sex hormone, the progestogen desogestrel. For this reason, Desogestrel is known as a progestogen-only pill (POP). Unlike combined pills, POPs do not contain oestrogen hormones in addition to the progestogen.
Most POPs work mainly by preventing sperm from entering the uterus, but they do not always prevent the egg from ripening, which is the main action of combined pills.
Desogestrel is different from other POPs because it has a dose that is high enough to prevent the egg from ripening in most cases. Therefore, Desogestrel provides high contraceptive efficacy.
Unlike the combined pill, Desogestrel STADA can be taken by women who do not tolerate oestrogens and by women who are breastfeeding. A disadvantage is that you may experience irregular vaginal bleeding during the use of Desogestrel. You may also not bleed at all.
Desogestrel STADA, like other hormonal contraceptives, does not protect against HIV infection (AIDS) or any other sexually transmitted disease.
Do not take Desogestrel STADA
Tell your doctor before using Desogestrel STADA if any of these conditions apply to you. Your doctor may recommend that you use a non-hormonal method of birth control.
Consult your doctor immediately if any of these conditions occur for the first time while using Desogestrel STADA.
Warnings and precautions
Consult your doctor, pharmacist, or nurse before starting Desogestrel STADA, especially if:
If you use Desogestrel STADA in any of these situations, you should remain under medical supervision. Your doctor can explain what you should do.
Breast cancer
Regularly examine your breasts and contact your doctor as soon as possible if you notice any lump in your breasts.
Breast cancer has been found slightly more often in women who take the Pill than in women of the same age who do not take the Pill. If women stop taking the Pill, the risk decreases gradually, so that 10 years after stopping the Pill, the risk is the same as for women who have never taken the Pill. Breast cancer is rare in women under 40 years of age, but the risk increases as women get older. Therefore, the additional number of breast cancers diagnosed is greater the older the woman is when she continues to take the Pill. The duration of use of the Pill is less important.
Of 10,000 women who have taken the Pill for up to 5 years and stop taking it around the age of 20, there will be less than 1 additional case of breast cancer diagnosed in the next 10 years, which will be added to the 4 cases normally diagnosed in this age group. Similarly, of 10,000 women who have taken the Pill for up to 5 years and stop taking it around the age of 30, there will be 5 additional cases, in addition to the 44 cases normally diagnosed. In 10,000 women who have taken the Pill for up to 5 years and stop taking it around the age of 40, there will be 20 additional cases, in addition to the 160 cases normally diagnosed.
It is believed that the risk of breast cancer in users of progestogen-only pills like Desogestrel STADA is similar to that of women who take the Pill, but the evidence is less conclusive.
It appears that breast cancers found in women who take the Pill are less advanced than breast cancers found in women who do not take the Pill.
It is not known whether the difference in breast cancer risk is due to the Pill. It may be that women who take the Pill are examined more often, so that breast cancer is detected earlier.
Thrombosis
Contact your doctor immediately if you notice any possible signs of thrombosis (see also "Regular check-ups").
Thrombosis is the formation of a blood clotthat can block a blood vessel. A thrombosis sometimes occurs in the deep veins of the legs (deep vein thrombosis). If the clot breaks loose from the veins where it has formed, it can reach and block the arteries of the lungs, causing what is known as a "pulmonary embolism". This can lead to life-threatening situations. Deep vein thrombosis is rare. It can develop when taking or not taking the Pill. It can also occur when you are pregnant.
The risk of thrombosis is greater in Pill users than in non-users. It is believed that the risk in users of progestogen-only pills like Desogestrel STADA is smaller than in users of Pills that also contain oestrogens (combined pills).
Psychiatric disorders
Some women who use hormonal contraceptives like desogestrel have reported depression or depressed mood. Depression can be severe and sometimes may lead to suicidal thoughts. If you experience mood changes and symptoms of depression, contact your doctor for further medical advice as soon as possible.
Children and adolescents
There are no clinical data available on the safety and efficacy in adolescents under 18 years of age.
Taking Desogestrel STADA with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Some medicines may cause Desogestrel STADA to not work properly. These include medicines used for the treatment of:
Your doctor will advise you if you need to take additional contraceptive precautions and for how long.
Desogestrel STADA may also interfere with the effect of some medicines, causing an increase in effect (e.g. medicines with ciclosporin) or a decrease in effect.
Pregnancy and breastfeedingIf you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Pregnancy
Do not use Desogestrel STADA if you are pregnant or think you may be pregnant.
Breastfeeding
Desogestrel STADA can be used during breastfeeding. Desogestrel does not appear to affect milk production or the quality of breast milk. However, it has been reported that desogestrel may cause a decrease in milk production. A small amount of the active substance of Desogestrel STADA passes into breast milk.
The health of children during breastfeeding for 7 months, whose mothers used other progestogen-only pills, has been studied until the children were 2.5 years old. No effects on the growth or development of the children were observed.
If you are breastfeeding and want to use Desogestrel STADA, contact your doctor.
Driving and using machines
There are no indications that the use of Desogestrel STADA has any effect on alertness or the ability to concentrate.
Desogestrel STADA contains lactose
If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
Regular check-ups
During treatment with Desogestrel STADA, your doctor will need you to have regular check-ups. In general, the frequency and nature of these check-ups will depend on your personal situation.
Contact your doctor as soon as possible if:
When and how to take the tablets
Each Desogestrel STADA blister pack contains 28 tablets. There are arrows printed on the front of the blister pack, between the tablets. If you turn the blister pack over and look at the back, you will see the days of the week printed on the foil. Each day corresponds to one tablet.
Every time you start a new Desogestrel STADA blister pack, take a tablet from the top row. Do not start with any tablet. For example, if you start on a Wednesday, you should take the tablet from the top row that is marked (on the back) with "WED". Continue taking one tablet a day until the blister pack is empty, always following the direction indicated by the arrows. Looking at the back of the blister pack, you can easily check if you have taken your tablet on a particular day.
Take your tablet every day at about the same time. Swallow the tablet whole with water. You may experience some bleeding during the use of Desogestrel STADA, but you should continue to take the tablets as usual. When the blister pack is empty, start a new Desogestrel STADA blister pack the next day - so without interruption and without waiting for a bleed to occur.
Starting the first Desogestrel STADA blister pack
Wait for your period to begin. Take the first tablet of Desogestrel STADA on the first day of your period. You do not need to take any additional contraceptive precautions.
You can also start on days 2-5 of your cycle, but in this case, make sure to use an additional contraceptive method (barrier method) for the first 7 days of tablet-taking.
You can start taking Desogestrel STADA the day after you take the last tablet from your current blister pack, or the day of removal of the vaginal ring or transdermal patch (this means you do not need to leave a gap between the tablets, ring, or patch). If your current blister pack contains inactive tablets, you can start taking Desogestrel STADA the day after you take the last active tablet (if you are not sure, consult your doctor or pharmacist). If you follow these instructions, you do not need to take any additional contraceptive precautions.
You can also start the day after the tablet-free interval of your current contraceptive, or the interval with an inactive tablet. If you follow these instructions, make sure to use an additional contraceptive method (barrier method) for the first 7 days of tablet-taking.
You can stop taking it at any time and start Desogestrel STADA immediately. You do not need to take any additional contraceptive precautions.
Start taking Desogestrel STADA at the time you would have received your next injection, or on the day you remove your implant or IUD. You do not need to take any additional contraceptive precautions.
You can start taking Desogestrel STADA between 21 and 28 days after giving birth. If you start later, make sure to use an additional contraceptive method (barrier method) until you have completed the first 7 days of tablet-taking. However, if you have already had sex, you should rule out pregnancy before starting Desogestrel STADA.
You can find more information about breastfeeding in "Pregnancy and breastfeeding" in section 2. Your doctor may also advise you.
Your doctor will advise you.
If you forget to take Desogestrel STADA
Take the missed tablet as soon as you remember, and take the next tablet at the usual time.
If you have gastrointestinal disorders (e.g. vomiting, severe diarrhoea)
Follow the instructions for missed tablets in the previous section. If you vomit or use activated charcoal within 3-4 hours after taking your Desogestrel STADA tablet, or have severe diarrhoea, it is possible that the active substance has not been completely absorbed.
If you take more Desogestrel STADA than you should
No serious harmful effects have been reported when taking too many Desogestrel STADA tablets at once. The symptoms that may occur are nausea, vomiting, and in young women, slight vaginal bleeding.
For more information, consult your doctor.
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicology Information Service immediately, telephone 91 562 04 20, indicating the medicine and the amount taken.
If you stop taking Desogestrel STADA
You can stop taking Desogestrel STADA whenever you want. From the day you stop taking it, you will no longer be protected against pregnancy.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Severe adverse effectsassociated with the use of Desogestrel STADA are described in the sections "Breast Cancer" and "Thrombosis" in section 2 "What you need to know before taking Desogestrel STADA". Read this section for additional information and consult your doctor as needed.
Irregular vaginal bleedingmay occur during the use of Desogestrel STADA. This can be just a slight spotting that may not require a pad, or more intense bleeding that resembles a scarce menstrual period and requires hygienic protection. It may also happen that you never experience bleeding. Irregular bleeding is not a sign that the contraceptive protection of Desogestrel STADA decreases. In general, you do not need to do anything, just continue taking this medicine. However, if the bleeding is intense or prolonged, consult your doctor.
Users of Desogestrel STADA have reported the following adverse effects:
Frequent (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Aside from these adverse effects, breast secretion may occur.
Consult your doctor immediately if you experience symptoms of angioedema, such as (i) swelling of the face, tongue, or throat; (ii) difficulty swallowing; or (iii) hives and difficulty breathing.
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this prospectus. You can also report them through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date shown on the packaging. The expiration date is the last day of the month indicated.
This medicine does not require special storage conditions.
Medicines should not be disposed of through wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE point in the pharmacy. Ask your pharmacist how to dispose of medicines you no longer need. This will help protect the environment.
Composition ofDesogestrel STADA
The active ingredient is desogestrel. Each tablet contains 75 micrograms of desogestrel.
The other components are: lactose, all racemic forms of tocopherol, povidone, potato starch, colloidal anhydrous silica, stearic acid.
(See also "Desogestrel STADA contains lactose" in section 2).
Appearance of the Product and Package Contents
Each tablet is round, uncoated, biconvex, engraved with "152" on one side and smooth on the other. Each package of Desogestrel STADA 75 micrograms tablets contains 1, 3, 6 or 13 blisters with 28 tablets each.
Each cardboard package contains blisters packaged separately in a laminated aluminum pouch.
Packages may be marketed with or without a desiccant.
Only some package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Laboratory STADA, S.L.
Frederic Mompou, 5
08960 Sant Just Desvern (Barcelona)
Spain
info@stada.es
Manufacturer
STADA Arzneimittel AG
Stadastrasse 2 – 18
61118 Bad Vilbel
Germany
or
STADA Arzneimittel GmBH.
Muthgasse 36
A-1190 Vienna
Austria
Date of the Last Revision of this Prospectus:September 2020
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
.